schliessen

Filtern

 

Bibliotheken

Draft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin

Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.

Journal Title: Genome Announcements 2013-08-08, Vol.1 (4)
Main Author: Baranasic, Damir
Other Authors: Gacesa, Ranko , Starcevic, Antonio , Zucko, Jurica , Blazic, Marko , Horvat, Marinka , Gjuracic, Kresimir , Fujs, Stefan , Hranueli, Daslav , Kosec, Gregor , Cullum, John , Petkovic, Hrvoje
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: United States: American Society for Microbiology
ID: ISSN: 2169-8287
Link: https://www.ncbi.nlm.nih.gov/pubmed/23929477
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3738893
title: Draft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin
format: Article
creator:
  • Baranasic, Damir
  • Gacesa, Ranko
  • Starcevic, Antonio
  • Zucko, Jurica
  • Blazic, Marko
  • Horvat, Marinka
  • Gjuracic, Kresimir
  • Fujs, Stefan
  • Hranueli, Daslav
  • Kosec, Gregor
  • Cullum, John
  • Petkovic, Hrvoje
subjects:
  • carbohydrates (lipids)
  • Prokaryotes
ispartof: Genome Announcements, 2013-08-08, Vol.1 (4)
description: Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 2169-8287
fulltext: fulltext
issn:
  • 2169-8287
  • 2169-8287
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.3256714
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3738893
sourceformatXML
sourcesystemPC
sourcerecordid1419344541
originalsourceidFETCH-LOGICAL-13828-87fd3b4b86dd442dcd1a27519e723646a8e29689d2dd2285a34ea794cfaa6e93
addsrcrecordideNp1kU1vFSEUhonR2KZ278qwdOGtw8cMsDFp6kdNbtqk7Z4wcKbFzMAIjEn_vYz3WluTsuHAOefhPbwIvSXNCSFUfryFECc4PWmaVpINYS_QISWd2kgqxctH8QE6zvlHU5esV1y-RgeUKaq4EIdo-ZzMUPCOhTP8XCBYwHHA1yXBXOJ0byHjZGZTIx-8XfKaMj7gi6urLW65Ih9wuQM8p-gWC2ltXs9-mpYQ8zLPCXI2ofyjvEGvBjNmON7vR-jm65ebs_PN9vLb97PTbZ2mKt9IMTjW8152znFOnXXEUNESBYKyjndGAlWdVI46R6lsDeNghOJ2MKYDxY7Qpx12XvoJnIVQhY96Tn4y6V5H4_XTTPB3-jb-0kwwKRWrgPMdIM4QjE_wpNcFKDo6TTuhneoN76mARljSqFYRp6ikwikFEqysqPd7LSnWT85FTz5bGEcTIC5ZE04U47zlpJY2u1KbYs4JhodXSaNX6_Xeev3Hek1Woe8eT_rQ8NfoWtD9x7S-mOLjOrgfnyf_Bvacvxg
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid1419344541
display
typearticle
titleDraft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin
sourceAlma/SFX Local Collection
creatorBaranasic, Damir ; Gacesa, Ranko ; Starcevic, Antonio ; Zucko, Jurica ; Blazic, Marko ; Horvat, Marinka ; Gjuracic, Kresimir ; Fujs, Stefan ; Hranueli, Daslav ; Kosec, Gregor ; Cullum, John ; Petkovic, Hrvoje
creatorcontribBaranasic, Damir ; Gacesa, Ranko ; Starcevic, Antonio ; Zucko, Jurica ; Blazic, Marko ; Horvat, Marinka ; Gjuracic, Kresimir ; Fujs, Stefan ; Hranueli, Daslav ; Kosec, Gregor ; Cullum, John ; Petkovic, Hrvoje
descriptionStreptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.
identifier
0ISSN: 2169-8287
1EISSN: 2169-8287
2DOI: 10.1128/genomeA.00581-13
3PMID: 23929477
languageeng
publisherUnited States: American Society for Microbiology
subjectcarbohydrates (lipids) ; Prokaryotes
ispartofGenome Announcements, 2013-08-08, Vol.1 (4)
rightsCopyright © 2013 Baranasic et al. 2013 Baranasic et al.
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-13828-87fd3b4b86dd442dcd1a27519e723646a8e29689d2dd2285a34ea794cfaa6e93
citesFETCH-LOGICAL-13828-87fd3b4b86dd442dcd1a27519e723646a8e29689d2dd2285a34ea794cfaa6e93
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23929477$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Baranasic, Damir
1Gacesa, Ranko
2Starcevic, Antonio
3Zucko, Jurica
4Blazic, Marko
5Horvat, Marinka
6Gjuracic, Kresimir
7Fujs, Stefan
8Hranueli, Daslav
9Kosec, Gregor
10Cullum, John
11Petkovic, Hrvoje
title
0Draft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin
1Genome Announcements
addtitleGenome Announc
descriptionStreptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.
subject
0carbohydrates (lipids)
1Prokaryotes
issn
02169-8287
12169-8287
fulltexttrue
rsrctypearticle
creationdate2013
recordtypearticle
recordideNp1kU1vFSEUhonR2KZ278qwdOGtw8cMsDFp6kdNbtqk7Z4wcKbFzMAIjEn_vYz3WluTsuHAOefhPbwIvSXNCSFUfryFECc4PWmaVpINYS_QISWd2kgqxctH8QE6zvlHU5esV1y-RgeUKaq4EIdo-ZzMUPCOhTP8XCBYwHHA1yXBXOJ0byHjZGZTIx-8XfKaMj7gi6urLW65Ih9wuQM8p-gWC2ltXs9-mpYQ8zLPCXI2ofyjvEGvBjNmON7vR-jm65ebs_PN9vLb97PTbZ2mKt9IMTjW8152znFOnXXEUNESBYKyjndGAlWdVI46R6lsDeNghOJ2MKYDxY7Qpx12XvoJnIVQhY96Tn4y6V5H4_XTTPB3-jb-0kwwKRWrgPMdIM4QjE_wpNcFKDo6TTuhneoN76mARljSqFYRp6ikwikFEqysqPd7LSnWT85FTz5bGEcTIC5ZE04U47zlpJY2u1KbYs4JhodXSaNX6_Xeev3Hek1Woe8eT_rQ8NfoWtD9x7S-mOLjOrgfnyf_Bvacvxg
startdate20130808
enddate20130808
creator
0Baranasic, Damir
1Gacesa, Ranko
2Starcevic, Antonio
3Zucko, Jurica
4Blazic, Marko
5Horvat, Marinka
6Gjuracic, Kresimir
7Fujs, Stefan
8Hranueli, Daslav
9Kosec, Gregor
10Cullum, John
11Petkovic, Hrvoje
generalAmerican Society for Microbiology
scope
0NPM
1AAYXX
2CITATION
37X8
4BOBZL
5CLFQK
65PM
sort
creationdate20130808
titleDraft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin
authorBaranasic, Damir ; Gacesa, Ranko ; Starcevic, Antonio ; Zucko, Jurica ; Blazic, Marko ; Horvat, Marinka ; Gjuracic, Kresimir ; Fujs, Stefan ; Hranueli, Daslav ; Kosec, Gregor ; Cullum, John ; Petkovic, Hrvoje
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-13828-87fd3b4b86dd442dcd1a27519e723646a8e29689d2dd2285a34ea794cfaa6e93
rsrctypearticles
prefilterarticles
languageeng
creationdate2013
topic
0carbohydrates (lipids)
1Prokaryotes
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Baranasic, Damir
1Gacesa, Ranko
2Starcevic, Antonio
3Zucko, Jurica
4Blazic, Marko
5Horvat, Marinka
6Gjuracic, Kresimir
7Fujs, Stefan
8Hranueli, Daslav
9Kosec, Gregor
10Cullum, John
11Petkovic, Hrvoje
collection
0PubMed
1CrossRef
2MEDLINE - Academic
3OpenAIRE (Open Access)
4OpenAIRE
5PubMed Central (Full Participant titles)
jtitleGenome Announcements
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Baranasic, Damir
1Gacesa, Ranko
2Starcevic, Antonio
3Zucko, Jurica
4Blazic, Marko
5Horvat, Marinka
6Gjuracic, Kresimir
7Fujs, Stefan
8Hranueli, Daslav
9Kosec, Gregor
10Cullum, John
11Petkovic, Hrvoje
formatjournal
genrearticle
ristypeJOUR
atitleDraft genome sequence of Streptomyces rapamycinicus Strain NRRL 5491, the producer of the immunosuppressant rapamycin
jtitleGenome Announcements
addtitleGenome Announc
date2013-08-08
risdate2013
volume1
issue4
issn2169-8287
eissn2169-8287
abstractStreptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.
copUnited States
pubAmerican Society for Microbiology
pmid23929477
doi10.1128/genomeA.00581-13
oafree_for_read